- Home
- WST vs NTRS Comparison
WST vs NTRS Comparison
Compare WST & NTRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WST
- NTRS
- Stock Information
- Founded
- WST 1923
- NTRS 1889
- Country
- WST United States
- NTRS United States
- Employees
- WST N/A
- NTRS N/A
- Industry
- WST Medical/Dental Instruments
- NTRS Major Banks
- Sector
- WST Health Care
- NTRS Finance
- Exchange
- WST Nasdaq
- NTRS Nasdaq
- Market Cap
- WST 15.6B
- NTRS N/A
- IPO Year
- WST N/A
- NTRS N/A
- Fundamental
- Price
- WST $222.00
- NTRS $131.70
- Analyst Decision
- WST Buy
- NTRS Hold
- Analyst Count
- WST 7
- NTRS 12
- Target Price
- WST $331.67
- NTRS $113.17
- AVG Volume (30 Days)
- WST 696.4K
- NTRS 2.9M
- Earning Date
- WST 07-24-2025
- NTRS 07-23-2025
- Dividend Yield
- WST 0.38%
- NTRS 2.28%
- EPS Growth
- WST N/A
- NTRS 137.54
- EPS
- WST 6.37
- NTRS 10.76
- Revenue
- WST $2,895,800,000.00
- NTRS $8,577,100,000.00
- Revenue This Year
- WST $3.38
- NTRS N/A
- Revenue Next Year
- WST $5.85
- NTRS $3.76
- P/E Ratio
- WST $34.87
- NTRS $12.24
- Revenue Growth
- WST N/A
- NTRS 28.50
- 52 Week Low
- WST $187.43
- NTRS $80.81
- 52 Week High
- WST $352.33
- NTRS $133.00
- Technical
- Relative Strength Index (RSI)
- WST 55.47
- NTRS 79.62
- Support Level
- WST $215.67
- NTRS $121.77
- Resistance Level
- WST $226.80
- NTRS $123.31
- Average True Range (ATR)
- WST 5.26
- NTRS 3.14
- MACD
- WST -0.05
- NTRS 1.54
- Stochastic Oscillator
- WST 65.84
- NTRS 94.98
About WST West Pharmaceutical Services Inc.
West Pharmaceutical Services is based in Pennsylvania, US, and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs, which include large molecule biologics, peptides such as GLP-1 receptor agonists, and small molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.